US Stock MarketDetailed Quotes

QLGN Qualigen Therapeutics

Watchlist

4.8310
+0.4110+9.30%

Close Nov 22 16:00 ET

5.0400
+0.2090+4.33%

Post 19:10 ET

3.56MMarket Cap-100P/E (TTM)

Qualigen Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

37.77%-1.8M

39.09%-1.47M

59.65%-783.59K

14.20%-9.09M

7.84%-1.84M

-272.85%-2.89M

38.65%-2.42M

49.97%-1.94M

28.05%-10.6M

31.51%-2M

Net income from continuing operations

44.54%-1.79M

58.26%-1.48M

37.16%-2.03M

10.22%-12.48M

31.44%-2.47M

-75.05%-3.24M

14.30%-3.54M

25.11%-3.24M

22.36%-13.89M

14.69%-3.6M

Operating gains losses

304.33%496.76K

81.06%-83.39K

112.11%125.74K

-64.50%-1.38M

-113.32%-24.02K

138.24%122.86K

-2,874.96%-440.29K

-52.02%-1.04M

81.04%-838.98K

243.68%180.37K

Depreciation and amortization

----

-63.05%4.5K

----

-96.40%12.17K

-96.59%3.04K

Other non cash items

-62.80%171.02K

-187.74%-223.02K

-71.32%461.93K

--2.55M

--222.44K

--459.68K

--254.18K

--1.61M

----

Change In working capital

-83.42%-700.79K

-58.81%275.34K

28.51%602.85K

272.91%1.11M

-52.84%356.09K

-743.66%-382.08K

150.98%668.47K

421.44%469.1K

-129.05%-642.87K

150.08%755.03K

-Change in prepaid assets

74.43%-211.04K

558.37%44.27K

303.98%721.45K

-108.48%-264.74K

49.24%375.36K

-585.57%-825.41K

100.81%6.72K

-36.69%178.58K

-109.78%-126.99K

13.49%251.51K

-Change in payables and accrued expense

-210.47%-489.76K

-65.08%231.07K

-140.83%-118.61K

366.79%1.38M

-103.83%-19.28K

302.33%443.34K

243.56%661.75K

185.61%290.52K

-136.01%-515.88K

1,897.76%503.52K

Cash from discontinued investing activities

54.29%-1.21M

-1,481.50%-3.83M

3.82M

-507.53K

-692.31K

-2.65M

-242.35K

Operating cash flow

-293.59%-1.8M

49.65%-1.47M

70.25%-783.59K

22.22%-10.3M

-153.45%-5.67M

129.22%929.74K

25.79%-2.93M

32.14%-2.63M

10.07%-13.25M

23.19%-2.24M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Investing cash flow

-129.57%-1.25M

823.01%350K

--0

2,394.23%4.22M

196.33%235.4K

37,642.93%4.23M

-139.84%-48.41K

-299.01%-198.01K

-29.99%-183.76K

-1,336.82%-244.38K

Financing cash flow

Cash flow from continuing financing activities

854.39%3.32M

1.15M

475K

-118.90%-550K

-103.79%-110K

-13,377.01%-440K

-65.49%2.91M

-64.37%2.9M

Net issuance payments of debt

--0

--1M

--475K

-118.94%-550K

-103.79%-110K

---440K

--0

2,193.03%2.9M

--2.9M

Net common stock issuance

----

--0

----

-100.01%-505

----

Proceeds from stock option exercised by employees

--265.98K

----

--0

----

-98.44%7.17K

--0

Cash from discontinued financing activities

Financing cash flow

854.39%3.32M

--1.15M

--475K

-118.90%-550K

-103.79%-110K

-13,377.01%-440K

--0

-65.49%2.91M

-64.37%2.9M

Net cash flow

Beginning cash position

-79.91%118.69K

-93.92%93.22K

-94.29%401.8K

-59.86%7.04M

-68.69%2.07M

-93.94%590.64K

-88.73%1.53M

-59.86%7.04M

-26.85%17.54M

-46.23%6.62M

Current changes in cash

-94.29%269.47K

100.86%25.47K

89.10%-308.59K

36.90%-6.64M

-1,416.63%-5.55M

247.86%4.72M

22.17%-2.98M

27.89%-2.83M

-63.41%-10.52M

-91.93%421.24K

Effect of exchange rate changes

----

--0

----

-30.06%-44.52K

--160.32K

--22.64K

---4.88K

End cash Position

-81.28%388.15K

-79.91%118.69K

-93.92%93.22K

-87.31%401.8K

-68.69%2.07M

-93.94%590.64K

-88.73%1.53M

-81.95%3.17M

Free cash flow

-293.59%-1.8M

49.65%-1.47M

70.25%-783.59K

22.22%-10.3M

-153.45%-5.67M

129.81%929.74K

26.05%-2.93M

33.00%-2.63M

10.92%-13.25M

23.64%-2.24M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	37.77%-1.8M	39.09%-1.47M	59.65%-783.59K	14.20%-9.09M	7.84%-1.84M	-272.85%-2.89M	38.65%-2.42M	49.97%-1.94M	28.05%-10.6M	31.51%-2M
Net income from continuing operations	44.54%-1.79M	58.26%-1.48M	37.16%-2.03M	10.22%-12.48M	31.44%-2.47M	-75.05%-3.24M	14.30%-3.54M	25.11%-3.24M	22.36%-13.89M	14.69%-3.6M
Operating gains losses	304.33%496.76K	81.06%-83.39K	112.11%125.74K	-64.50%-1.38M	-113.32%-24.02K	138.24%122.86K	-2,874.96%-440.29K	-52.02%-1.04M	81.04%-838.98K	243.68%180.37K
Depreciation and amortization	----	----	----	-63.05%4.5K	----	----	----	----	-96.40%12.17K	-96.59%3.04K
Other non cash items	-62.80%171.02K	-187.74%-223.02K	-71.32%461.93K	--2.55M	--222.44K	--459.68K	--254.18K	--1.61M	----	----
Change In working capital	-83.42%-700.79K	-58.81%275.34K	28.51%602.85K	272.91%1.11M	-52.84%356.09K	-743.66%-382.08K	150.98%668.47K	421.44%469.1K	-129.05%-642.87K	150.08%755.03K
-Change in prepaid assets	74.43%-211.04K	558.37%44.27K	303.98%721.45K	-108.48%-264.74K	49.24%375.36K	-585.57%-825.41K	100.81%6.72K	-36.69%178.58K	-109.78%-126.99K	13.49%251.51K
-Change in payables and accrued expense	-210.47%-489.76K	-65.08%231.07K	-140.83%-118.61K	366.79%1.38M	-103.83%-19.28K	302.33%443.34K	243.56%661.75K	185.61%290.52K	-136.01%-515.88K	1,897.76%503.52K
Cash from discontinued investing activities	0	0	0	54.29%-1.21M	-1,481.50%-3.83M	3.82M	-507.53K	-692.31K	-2.65M	-242.35K
Operating cash flow	-293.59%-1.8M	49.65%-1.47M	70.25%-783.59K	22.22%-10.3M	-153.45%-5.67M	129.22%929.74K	25.79%-2.93M	32.14%-2.63M	10.07%-13.25M	23.19%-2.24M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow	-129.57%-1.25M	823.01%350K	--0	2,394.23%4.22M	196.33%235.4K	37,642.93%4.23M	-139.84%-48.41K	-299.01%-198.01K	-29.99%-183.76K	-1,336.82%-244.38K
Financing cash flow
Cash flow from continuing financing activities	854.39%3.32M	1.15M	475K	-118.90%-550K	-103.79%-110K	-13,377.01%-440K	0	0	-65.49%2.91M	-64.37%2.9M
Net issuance payments of debt	--0	--1M	--475K	-118.94%-550K	-103.79%-110K	---440K	--0	--0	2,193.03%2.9M	--2.9M
Net common stock issuance	----	----	----	--0	--0	----	----	----	-100.01%-505	----
Proceeds from stock option exercised by employees	--265.98K	----	----	--0	--0	--0	----	----	-98.44%7.17K	--0
Cash from discontinued financing activities	0	0	0	0	0	0	0	0	0	0
Financing cash flow	854.39%3.32M	--1.15M	--475K	-118.90%-550K	-103.79%-110K	-13,377.01%-440K	--0	--0	-65.49%2.91M	-64.37%2.9M
Net cash flow
Beginning cash position	-79.91%118.69K	-93.92%93.22K	-94.29%401.8K	-59.86%7.04M	-68.69%2.07M	-93.94%590.64K	-88.73%1.53M	-59.86%7.04M	-26.85%17.54M	-46.23%6.62M
Current changes in cash	-94.29%269.47K	100.86%25.47K	89.10%-308.59K	36.90%-6.64M	-1,416.63%-5.55M	247.86%4.72M	22.17%-2.98M	27.89%-2.83M	-63.41%-10.52M	-91.93%421.24K
Effect of exchange rate changes	----	--0	--0	--0	----	----	-30.06%-44.52K	--160.32K	--22.64K	---4.88K
End cash Position	-81.28%388.15K	-79.91%118.69K	-93.92%93.22K	-87.31%401.8K	-87.31%401.8K	-68.69%2.07M	-93.94%590.64K	-88.73%1.53M	-81.95%3.17M	-81.95%3.17M
Free cash flow	-293.59%-1.8M	49.65%-1.47M	70.25%-783.59K	22.22%-10.3M	-153.45%-5.67M	129.81%929.74K	26.05%-2.93M	33.00%-2.63M	10.92%-13.25M	23.64%-2.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data